EU Court Cuts Astrazeneca Antitrust Fine To EUR52.5M Vs EUR60M

1st Jul 2010 08:52

LUXEMBOURG (Dow Jones)--A European Union court Thursday reduced an antitrust fine against AstraZeneca (AZN) and its Swedish subsidiary AstraZeneca AB for abusing their dominant position in the market by trying to prevent generic competition for ulcer drug Losec to EUR52.5 million from EUR60 million. The European Commission fined AstraZeneca EUR46 million and subsidiary AstraZeneca AB EUR14 million under then-new rules on patent extensions. The commission said it took the action in support of European healthcare systems who used generic drugs to keep costs down. -By Mike Gordon, Dow Jones Newswires; +352 691 180 766; [email protected] (END) Dow Jones Newswires July 01, 2010 03:52 ET (07:52 GMT)